• Profile
Close
Question
Which therapeutic approach provides the greater prolonged PFS and improved ORR in patients with advanced renal cell carcinoma of intermediate or poor risk?
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay